By Patient Advocate Foundation
The future of medicine has never been so bright. Many advances in treatments are being announced every day that can help eliminate disease or improve the life of patients suffering from illness. Even more drugs and treatment options that have the potential to improve the health of individuals, communities, and populations are currently in development in medical facilities and laboratories across the country. As part of the development and approval process, it is crucial that these new treatments are studied to make sure that they are safe and as effective, or more effective, than current standard treatment options.
When a person is diagnosed with a life-threatening, chronic, or debilitating illness, his or her medical team will present options to consider for treatment; these might include options known as current standard-of-care treatment or, in some situations, options within clinical trials. The National Cancer Institute (NCI) defines standard of care as: “Treatment that is accepted by medical experts as a proper treatment for a certain type of disease and that is widely used by healthcare professionals.”1 Healthcare providers are obligated to provide patients with access to standard-of-care treatment and best practices associated with the diagnosis.
Care that goes beyond or provides alternative options from what is considered the standard-of-care treatment can be delivered through clinical trials. Participating in a clinical trial may be exceptionally beneficial for a patient who is not finding success using the standard treatment protocol and is ready to consider alternative options.
Making the decision to enroll in a clinical trial is a personal one. There are a lot of potential benefits, such as expanded access to the newest medical therapies and cutting-edge technology. Because trials are studying previously untried combinations of therapies or new drugs coming to the marketplace, however, successful results are not guaranteed and both the risk factors and the side effects must be considered carefully.
Benefits And Risks Associated With A Trial
There are many benefits of participating in a clinical trial:
- You have access to promising new treatment approaches that are often not available outside a clinical trial setting.
- The approach being studied may be more effective than the standard approach.
- You receive regular and careful medical attention from a research team that includes doctors and other health professionals.
- You may be the first to benefit from the new method under study.
- Results from the study may help others in the future.
There are also risks associated with participating in a clinical trial:
- New drugs or procedures under study are not always better than the standard care with which they are being compared.
- There may be unpleasant, serious, or even life-threatening side effects from treatment.
- Treatment may not be effective for some individuals.
- Health insurance may not cover all study costs.
- The study may require a lot of time for traveling to the study site, receiving treatments, or hospital stays. This may incur additional costs associated with transportation.
What Defines A Clinical Trial, And How Is It Structured?
The most common clinical trial involves studying new drugs, combinations of drugs (some already approved by the US Food and Drug Administration [FDA] for other purposes), and treatments to see how well they work—especially when compared with current standard-of-care treatment. Clinical trials have protocols, or action plans, that describe how the trial will be conducted. The protocol helps the participant understand what will be done, how it will be done, and why each part is necessary.
All clinical trials are overseen by an independent committee of physicians, statisticians, and community members, who must approve and monitor the protocol; this group is referred to as an Institutional Review Board (IRB). The IRB makes sure that the risks as outlined in the protocol are small and are justified by the potential benefits.
Depending on the study, clinical trials have different eligibility requirements. Some studies need volunteers with a certain disease, whereas other studies require healthy people; some trials want all female participants, whereas others want all male participants. The sponsor of the study writes the protocol, which describes what the trial will do, how the trial will be conducted, the location of the study, eligibility criteria, and how and when the participants will be evaluated.
Clinical trials are sponsored by a variety of sources, including physicians, medical institutions, the National Cancer Institute, the Department of Defense, the Department of Veterans Affairs, and biopharmaceutical manufacturers.
The nature and the purpose of the trial define how it will be conducted.2 There are several different types of trials:
- Treatment trials test experimental treatments, new combinations of drugs, and new approaches to surgery or radiation therapy.
- Prevention trials look for better ways to ward off disease in people who have never had a specific disease or to prevent a disease from returning. Approaches may include medicines, vaccines, vitamins, minerals, and lifestyle changes.
- Diagnostic trials are conducted to find better tests or procedures for diagnosing a particular disease or condition.
- Screening trials test the best way to detect certain diseases or health conditions.
- Quality-of-life trials (or supportive care trials) explore ways to improve comfort and quality of life for cancer patients and survivors.
What Are The Phases Of Clinical Trials?
In the United States, the FDA requires that all new drugs and treatments complete multiple layers of testing before becoming available to the general public. Clinical trial phases are stages designed to test the new treatments and care standards being proposed. Once all phases are complete, evidence proving that the drug is safe and that the benefits of using the drug outweigh the risks must be presented before the drug can gain FDA approval for use as standard of care.
PHASE I. When a drug or treatment is in a Phase I trial, the researchers are trying to determine how the drug or treatment will be administered (orally, intravenously). The researchers are looking for the proper dose and monitoring side effects. The study focuses on a small group of participants.
PHASE II. When a drug or treatment advances to a Phase II trial, the researchers are studying the results to determine the effectiveness of the drug or treatment. Phase II trials collect information on the safety and benefits of the treatment. The study expands to 100 or more participants.
PHASE III. When a drug or treatment advances to a Phase III trial, the researchers are determining if one treatment is better than another. The trial agent is studied in comparison with current standard-of-care treatment. Phase III trials expand in size from several hundred to thousands of participants.
PHASE IV. When a drug or treatment advances to a Phase IV trial, the researchers are monitoring long-term safety and effectiveness of the treatment. These are also known as post-marketing surveillance studies.3
As a drug or treatment advances in each phase of a clinical trial, the number of institutions or facilities offering the trial increases. Clinical trials can be conducted in medical centers, community clinics, or doctors’ offices, so location is an important aspect to consider as you examine whether a trial is right for your situation.
Trial participants are assigned to random groups, with each group receiving the specific treatment being tested or a placebo (“sugar pill,” or dummy medical treatment). It is important to know, however, that in cancer clinical trials, participants always receive either the current standard-of-treatment protocol or the new drug treatment protocol and do not go without treatment.
To be sure that trial results are free of any outside influence, neither the doctors, the person administering the treatment, nor the study participant know to which treatment group study participants are assigned. This study technique is known as a double-blind study and is common among respected research studies.
To be eligible to participate in a clinical trial, there are specific criteria, or guidelines, that must be met. These guidelines are developed by the researchers to define the target population. Eligibility guidelines that allow participation in a clinical trial are called inclusion criteria, and those that prevent participation are called exclusion criteria.
Three Misconceptions About Stem Cell Therapy From an Insider
What are the misconceptions regarding stem cell therapy?
Eligibility criteria can include the following:
- Type of illness or diagnosis
- Stage (extent) of the cancer, if cancer diagnosis is required
- Previous treatments that you must, or could not, have had
- Length of time since you last received treatment
- Results of certain laboratory tests
- Medicines that you are taking
- Other medical conditions
- Previous history of any other cancer or diagnosis of interest
- Other conditions specific to each clinical trial4
- Age and gender
The more representative the final clinical trial group is of the national population, the better researchers are able to adequately measure the outcomes and finalize the protocols for distribution among patients in all areas. So, no matter what race or ethnic background you have, what your gender and age are, or where you live, we encourage you to review the eligibility criteria for the clinical trials in your area.
Lazarex Cancer Foundation
lazarex.org or (877) 866-9523
Provides financial assistance to defray costs associated with clinical trial participation; also assists patients with navigation through clinical trial options and education.
My Resource Search Mobile App
This mobile search tool allows patients to search any of 35 available categories of assistive programs, including transportation, utilities, clinical trial assistance, pharmaceutical support, and more. It is available for free from both Apple and Android app stores.
How to Find A Clinical Trail
Talk to your doctor if you are interested in a clinical trial for your medical diagnosis, as he or she may be able to connect you to relevant and current studies. You may also search through clinical trial databases at any point through a registry website:
- US National Institutes of Health clinical studies finder, clinicaltrials.gov
- National Cancer Institute clinical trials finder, cancer. gov/clinicaltrials or (800) 4-CANCER [800-422- 6237]
- EmergingMed clinical trials navigator services, emergingmed.com or (877) 601-8601
- Select Clinical Trials finder, selectclinicaltrials.com
Your Rights Within A Clinical Trial
Once you are evaluated and deemed eligible for the trial, the trial research team must clearly and completely explain the trial’s purpose, procedures, risks, and benefits and obtain informed consent before you can participate. You will receive documentation regarding the details of the study; purpose of the trial; duration, or length of time the trial will run; required testing such as lab work and scans; key contacts; and what costs, if any, you are responsible to cover. You may discuss these documents with your doctors or other trusted medical professionals to help you understand any terminology as well as seek their guidance if desired.
Even if you decide to move forward under the clinical trial, by signing the informed consent you are not obligated to participate for the full duration of the trial—you have the right to leave the study at any time. If you choose to leave the study, your doctor will discuss other treatment options.
You have the following rights as a clinical trial participant:
- To understand all of your treatment options
- To know what is involved in the trial, such as tests, risks, and benefits
- To have the opportunity to discuss the trial with the investigator and research team before and during the trial
- To hear and read information in a language you can understand
- To end care through the clinical trial and leave the clinical trial at any point
- NCI Dictionary of Cancer Terms: standard of care. National Cancer Institute website. Accessed October 5, 2014.
- NIH Clinical Research Trials and You. National Institutes of Health website. Accessed October 5, 2014.
- Learn about Clinical Studies. ClinicalTrials.gov website. Accessed October 5, 2014.
- Learn about Clinical Trials. National Cancer Institute website. Accessed October 5, 2014.
Is Participating in a Clinical Trial Right for You?
CancerConnect News: While the decision whether or not to enroll in a clinical trial of a novel cancer treatment is ultimately very personal, a clear understanding of the nature of clinical trials can help you make the choice that’s right for you. Once you carefully weigh the pros and cons of clinical trials, you’ll be prepared to make a thoughtful and informed decision that supports your cancer treatment plan.
A clear understanding of what clinical trials are is a good place to start:
Cancer clinical trials are studies that evaluate the effectiveness and safety of new cancer drugs or cancer treatment strategies. The development of more effective cancer treatment requires that new and innovative therapies be evaluated with cancer patients. Each clinical trial is designed to find new or better ways to treat cancer patients. In oncology, clinical trials are especially important because, in the absence of high cure rates, nearly all cancer treatment approaches are developmental in nature. All new cancer drugs that are currently available in the United States were once only available in clinical trials. In the U.S. all new cancer treatment products must proceed through an orderly clinical trials evaluation process to ensure that they have an acceptable level of safety and demonstrate benefit to patients with a specific cancer before they become commercially available to other patients.
The Pros of Clinical Trials
- Participating patients are treated with carefully designed cancer treatment regimens that are either the best standard treatments available or approaches that may become standard treatments.
- Participation is an integral part of the research process. Small improvements in cancer treatment can only be detected in Phase III clinical trials, the phase in which the experimental drug or treatment is given to large groups of people to confirm effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will contribute to safe use of the drug or treatment. A greater number of patients allows for a more efficient and thorough process.
- In some cases the best cancer treatment may be available only in a clinical trial.
- Participants receive correct dosages as a result of carefully designed regimens and strict protocol, and correct dosage often contributes to the effectiveness of a cancer treatment regimen.
- Thanks to “stopping rules”, which are included in all cancer research protocols, clinical trials are stopped when one cancer treatment is proven to be superior so that no patient is intentionally given an inferior treatment.
- The medical community gains knowledge about the treatment of cancer that can be used to treat other cancer patients and to develop newer cancer treatments.
The Cons of Clinical Trials
- Clinical trials are not available for all cancers or all patients.
- Patients in Phase III clinical trials are assigned at random to either the experimental or control group—a process that makes some people uncomfortable.
- Participation in a clinical trial may offer no benefit.
Understanding the pros and cons of clinical trials in oncology may help you decide whether or not participation in a clinical trial is an appropriate choice, but it’s important to remember that the decision is entirely your own. In other words, you shouldn’t feel pressure from any outside sources to enroll in a clinical trial. If you do choose to participate or further research clinical trial opportunities, you may wish to discuss with your physician the potential risks and benefits of these studies as well as your other treatment options.